Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Terminated 1Recruiting 1Completed 1

Sponsor Class

OTHER 2FED 1

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Gastrointestinal 16Breast 13Other 8Genitourinary 6Lymphoid 5Other hematologic neoplasm 4Gynecologic 4Thoracic 3Endocrine 3Tumor-Agnostic 2Myeloid 1Head & Neck 1Dermatologic 1CNS 1

Conditions

Lung Neoplasms 2Weight Loss 1Urologic Neoplasms 1Smoking Cessation 1Prostatic Neoplasms 1Neoplasms 1Gastrointestinal Neoplasms 1Fasting 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Carboplatin 1174Cisplatin 891Pemetrexed 847pembrolizumab 626Paclitaxel 609Docetaxel 539Gemcitabine 428Radiotherapy 393Erlotinib Hydrochloride 381Nivolumab 344Bevacizumab 337Etoposide 297durvalumab 264Drug Therapy 260osimertinib 237atezolizumab 225Radiosurgery 196Gefitinib 186Vinorelbine 149Magnetic Resonance Spectroscopy 132Ipilimumab 129130-nm albumin-bound paclitaxel 125Cetuximab 113Blood Specimen Collection 106anlotinib 105tislelizumab 103Topotecan 103Specimen Handling 102Surgical Procedures, Operative 101Cyclophosphamide 101

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Diet × Thoracic × Clear all
NCT06671613 2025-11-10

Stage IV NSCLC

VA Office of Research and Development

Phase NA Recruiting
66 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Fasting

NCT03785808 2019-08-12

RIGHT

Fred Hutchinson Cancer Center

Phase NA Terminated
3 enrolled
Thoracic

Lung Neoplasms

NCT03410641 2018-01-25

Long-term Cancer Risk in the Randomised Oslo Diet and Antismoking Study

Oslo University Hospital

Completed
1,216 enrolled
GastrointestinalGenitourinaryThoracic

Gastrointestinal Neoplasms, Lung Neoplasms, Neoplasms, Prostatic Neoplasms, Urologic Neoplasms, Weight Loss, Smoking Cessation

Data powered by HemOnc (CC BY 4.0) Colophon âš¡